18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 7, 2009, Pages 1131-1137

  Keijsers, Ruth G ^a   Verzijlbergen, Fred J ^a   Oyen, Wim J ^b   Van Den Bosch, Jules M ^a   Ruven, Henk J ^a   Van Velzen Blad, Heleen ^a   Grutters, Jan C ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F FDG PET; Angiotensin converting enzyme; Sarcoidosis; Soluble interleukin 2 receptor

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FLUORODEOXYGLUCOSE F 18; INTERLEUKIN 2 RECEPTOR; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; CHEMISTRY; GENETICS; METABOLISM; MIDDLE AGED; SCINTISCANNING; SOLUBILITY;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, INTERLEUKIN-2; RETROSPECTIVE STUDIES; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SOLUBILITY;

EID: 67349276443     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1097-x     Document Type: Article

References (32)

1. MC Iannuzzi BA Rybicki AS Teirstein 2007 Sarcoidosis N Engl J Med 357 2153 2165
2. RP Baughman EE Lower RM du Bois 2003 Sarcoidosis Lancet 361 1111 1118 (Pubitemid 36369566)
3. S Gilbert DS Steinbrech SK Landas GW Hunninghake 1993 Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease Am Rev Respir Dis 148 483 486 (Pubitemid 23221598)
4. LA Rubin CC Kurman ME Fritz WE Biddison B Boutin R Yarchoan 1985 Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro J Immunol 135 3172 3177 (Pubitemid 16250575)
5. E Silverstein J Friedland HA Lyons A Gourin 1976 Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: clinical and possible pathogenic significance Ann N Y Acad Sci 278 498 513
6. PR Studdy R Lapworth R Bird 1983 Angiotensin-converting enzyme and its clinical significance-a review J Clin Pathol 36 938 947
7. PS Bunting JP Szalai M Katic 1987 Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis Clin Biochem 20 213 219 (Pubitemid 17127092)
8. H Klech H Kohn F Kummer A Mostbeck 1982 Assessment of activity in sarcoidosis. Sensitivity and specificity of 67gallium scintigraphy, serum ACE levels, chest roentgenography, and blood lymphocyte subpopulations Chest 82 732 738 (Pubitemid 13220879)
9. B Rigat C Hubert F Alhenc-Gelas F Cambien P Corvol F Soubrier 1990 An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 86 1343 1346 (Pubitemid 20370444)
10. E Arbustini M Grasso G Leo C Tinelli R Fasani M Diegoli 1996 Polymorphism of angiotensin-converting enzyme gene in sarcoidosis Am J Respir Crit Care Med 153 851 854 (Pubitemid 26051372)
11. P Sharma I Smith G Maguire S Stewart J Shneerson MJ Brown 1997 Clinical value of ACE genotyping in diagnosis of sarcoidosis Lancet 349 1602 1603 (Pubitemid 27229146)
12. GS Stokes JC Monaghan AP Schrader CL Glenn M Ryan BJ Morris 1999 Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity Aust N Z J Med 29 315 318 (Pubitemid 29322899)
13. H Tomita Y Ina Y Sugiura S Sato H Kawaguchi M Morishita 1997 Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis Am J Respir Crit Care Med 156 255 259 (Pubitemid 27293198)
14. J Müller-Quernheim 1998 Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology Sarcoidosis Vasc Diffuse Lung Dis 15 22 37 (Pubitemid 28174894)
15. S Rothkrantz-Kos MP van Dieijen-Visser PG Mulder M Drent 2003 Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis Clin Chem 49 1510 1517 (Pubitemid 37011740)
16. JC Grutters JM Fellrath L Mulder R Janssen JM van den Bosch H van Velzen-Blad 2003 Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation Chest 124 186 195 (Pubitemid 36851351)
17. No authors listed 1999 Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999 Am J Respir Crit Care Med 160 736 755
18. R Boellaard WJ Oyen CJ Hoekstra OS Hoekstra EP Visser AT Willemsen 2008 The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials Eur J Nucl Med Mol Imaging 35 2320 2333
19. PL Hurst CJ Lovell-Smith 1981 Optimized assay for serum angiotensin-converting enzyme activity Clin Chem 27 2048 2052 (Pubitemid 12194441)
20. HM Neels SL Scharpé ME van Sande RM Verkerk KJ Van Acker 1982 Improved micromethod for assay of serum angiotensin converting enzyme Clin Chem 28 1352 1355
21. A Kruit JC Grutters WB Gerritsen S Kos WK Wodzig JM van den Bosch 2007 ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis Respir Med 101 510 515 (Pubitemid 46196325)
22. JE Crabtree LD Juby RV Heatley AJ Lobo DW Bullimore AT Axon 1990 Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity Gut 31 1033 1036 (Pubitemid 20295941)
23. B Zerler 1991 The soluble interleukin-2 receptor as a marker for human neoplasia and immune status Cancer Cells 3 471 479
24. JJ Braun R Kessler A Constantinesco A Imperiale 2008 (18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases Eur J Nucl Med Mol Imaging 35 1537 1543
25. Y Yamada Y Uchida K Tatsumi T Yamaguchi H Kimura H Kitahara 1998 Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis J Nucl Med 39 1160 1166 (Pubitemid 28326144)
26. Y Nishiyama Y Yamamoto K Fukunaga H Takinami Y Iwado K Satoh 2006 Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis J Nucl Med 47 1571 1576 (Pubitemid 47545019)
27. JA Bons M Drent FG Bouwman EC Mariman MP van Dieijen-Visser WK Wodzig 2007 Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum Respir Med 101 1687 1695
28. R Kubota S Yamada K Kubota K Ishiwata N Tamahashi T Ido 1992 Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography J Nucl Med 33 1972 1980
29. J Müller-Quernheim 1998 Sarcoidosis: immunopathogenetic concepts and their clinical application Eur Respir J 12 716 738 (Pubitemid 28420156)
30. GM Ainslie SR Benatar 1985 Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy Q J Med 55 253 270 (Pubitemid 15028241)
31. Y Ina K Takada T Sato M Yamamoto M Noda M Morishita 1992 Soluble interleukin 2 receptors in patients with sarcoidosis. Possible origin Chest 102 1128 1133
32. N Keicho K Kitamura F Takaku H Yotsumoto 1990 Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis Chest 98 1125 1129 (Pubitemid 20381274)